GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) » Definitions » Accounts Payable & Accrued Expense

Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Accounts Payable & Accrued Expense : ¥1,323 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Zhuzhou Qianjin Pharmaceutical Co Accounts Payable & Accrued Expense?

Zhuzhou Qianjin Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥1,301 Mil) to Dec. 2023 (¥1,271 Mil) but then increased from Dec. 2023 (¥1,271 Mil) to Mar. 2024 (¥1,323 Mil).

Zhuzhou Qianjin Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥965 Mil) to Dec. 2022 (¥1,399 Mil) but then declined from Dec. 2022 (¥1,399 Mil) to Dec. 2023 (¥1,271 Mil).

Zhuzhou Qianjin Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Zhuzhou Qianjin Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhuzhou Qianjin Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Zhuzhou Qianjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 906.83 1,055.80 964.74 1,398.55 1,270.89

Zhuzhou Qianjin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,332.25 1,258.77 1,301.03 1,270.89 1,323.40

Zhuzhou Qianjin Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhuzhou Qianjin Pharmaceutical Co Ltd (SHSE:600479) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SZSE:002728 SZSE:002437 SZSE:002793 SZSE:301211 SZSE:300194 SZSE:300158 SHSE:688131 SHSE:688566 SZSE:002393 SHSE:600351 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
No. 15 Jinshangou Road, Hetang District, Zhuzhou, Hunan, CHN, 412003
Website
http://www.cnqjyy.com
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules.

Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Headlines

No Headlines